CL vs SER · P/E 34, rev $20.38B vs rev $56.0K
Colgate-Palmolive Company (CL) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the CL and SER stock pages for the full models.
Not investment advice.